Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects

OBJECTIVE: In the treatment of diabetic patients, the long-acting insulin analog insulin detemir is less prone to induce weight gain than other insulin formulations. Assuming that because of its pharmacologic properties, detemir displays stronger central nervous anorexigenic efficacy than human insu...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Hallschmid, Manfred, Jauch-Chara, Kamila, Korn, Oliver, Mölle, Matthias, Rasch, Björn, Born, Jan, Schultes, Bernd, Kern, Werner
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Diabetes Association 2010
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2844819/
https://ncbi.nlm.nih.gov/pubmed/20068139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1493
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια